Ameritas Investment Partners’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-2,784
| Closed | -$299K | – | 3287 |
|
|
2023
Q1 | $299K | Hold |
2,784
| – | – | 0.01% | 906 |
|
|
2022
Q4 | $322K | Buy |
2,784
+468
| +20% | +$54.2K | 0.01% | 900 |
|
|
2022
Q3 | $136K | Hold |
2,316
| – | – | 0.01% | 1291 |
|
|
2022
Q2 | $65K | Hold |
2,316
| – | – | ﹤0.01% | 1826 |
|
|
2022
Q1 | $87K | Hold |
2,316
| – | – | ﹤0.01% | 1741 |
|
|
2021
Q4 | $92K | Buy |
2,316
+1,430
| +161% | +$56.8K | ﹤0.01% | 1738 |
|
|
2021
Q3 | $21K | Hold |
886
| – | – | ﹤0.01% | 2685 |
|
|
2021
Q2 | $22K | Buy |
+886
| New | +$22K | ﹤0.01% | 2700 |
|